Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
Camoteskimab by Apollo Therapeutics for Atopic Dermatitis (Atopic Eczema): Likelihood of Approval
Camoteskimab is under clinical development by Apollo Therapeutics and currently in Phase II for Atopic Dermatitis (Atopic Eczema). According to...